Deutsche Bank Raises Medco (MHS) to Buy; Says Overhangs Removed

Deutsche Bank upgraded shares of Medco Health Solutions (NYSE: MHS) from Hold to Buy in late-session trade Wednesday following the company's Q3 results and raised guidance this morning. The analyst boosted his price target from $56 to $60.

Analysts Ross Muken and Michael Cherny cite "increased comfort with deal closure and marginalized downside risk post recent guidance / contract loss disclosures..." The analysts see a standalone stock value of $47 per share if a deal does not go through.

For more ratings news on Medco Health Solutions click here and for the rating history of Medco Health Solutions click here.

---

Serious News for Serious Traders! Try StreetInsider.com Premium Free!

---

You May Also Be Interested In

• Barrick Mining said to delay IPO of American gold business to 2027
• Deutsche Bank Upgrades Sirius XM Radio (SIRI) to Buy, 'mispriced based on a large disconnect between consensus estimates and what we believe the company can achieve
• Bernstein SocGen: 'We view AI as a significant long-term opportunity for UnitedHealth Group (UNH)'